INDEX PHARM. AB AK B O.N.
Healthcare · EUR · F
Price
€2.07
Cap
€319.34M
Earnings
—
30d Trend
-4.7%
52% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 43×Macro 0.99 (−1%)=43
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Potential value play — but fundamentals need strengthening
BRAIN47'S ASSESSMENT
I rate INDEX PHARM. AB AK B O.N. at 43/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 90/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-1.4%
3 MONTHS
-30.2%
12 MONTHS
-37.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Potential value play — but fundamentals need strengthening. Fundamentals (90) and Technical (42) are the primary strengths. I note that momentum is the weakest area at 13/100 — this warrants monitoring. Historical volatility is elevated at 52%. I classify this as a speculative position — elevated volatility at 52% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.